Partner Therapeutics Competitors and Similar CompaniesClear all

Partner Therapeutics's competitors and similar companies include Halozyme Therapeutics, OncoTherapy Science, Elea Laboratories and Numab.

	Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.	Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.	Elea Laboratories Elea Laboratories is a pharmaceutical company.	Numab Numab Therapeutics is an oncology-focused biopharmaceutical company.
Founding Date	Founding Date 2017	Founding Date 1998	Founding Date 2001	Founding Date 1939	Founding Date 2011
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare drug development oncology therapy	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare distribution drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Lexington, US HQ Boston, US Lynnwood, US	Locations San Diego, US HQ	Locations Kawasaki, JP HQ	Locations Buenos Aires, AR HQ	Locations Wädenswil, CH HQ
Employees	Employees 1891% decrease	Employees 373157% increase	Employees 54	Employees 1,5071% increase	Employees 693% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 6.4 b	Valuation ($) 56.9 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1b (FY, 2024)	Revenue (est.) ¥610.1m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $159.4m (FY, 2024)	Cost of goods ¥787.8m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $855.9m (FY, 2024)	Gross profit (¥177.7m) (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income $444.1m (FY, 2024)	Net income (¥1.3b) (FY, 2024)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 60m (about 7 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 110m (almost 4 years ago)
Total funding raised	Total funding raised $ 60m	Total funding raised $ 171.9m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 132.3m